Close the exclusive license agreement with Hengrui Pharma for an oral Lp(a) inhibitor
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 24 Apr 2025
- Due
- 30 Jun 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Exclusive License Agreement With Hengrui Pharma for an Investigational Oral Small Molecule Lp(a) Inhibitor; Transaction Expected to Close in Second Quarter 2025”
What we found
Evidence strength A What the grades mean
A 10-Q filed 2025-08-05 states the Hengrui license agreement closed in May 2025, within the Q2 2025 deadline. No specific day is given.
-
A Merck & Co., Inc. 10-Q filed 2025-08-05
“In May 2025, Merck and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) closed an exclusive license agreement for MK-7262 (HRS-5346), an investigational oral small molecule Lipoprotein(a) inhibitor” ✓ confirmed on the page
-
A Merck & Co., Inc. 10-K filed 2026-02-24
“In May 2025, Merck and Hengrui Pharma closed an exclusive license agreement for MK-7262 (HRS-5346)” ✓ confirmed on the page
Market reaction: the shares moved +0.5% against the S&P 500 over the three sessions around the disclosure (4 Aug 2025 to 7 Aug 2025). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Transaction other
- Indicative materiality
- Medium rules
- Action
- Close
- Deliverable
- Hengrui Pharma exclusive license for oral Lp(a) inhibitor
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Merck & Co., Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-MRK-005961 · Corrections policy